Chemotherapy Patient Articles & Analysis
13 articles found
Participation may offer patients access to the latest advancements in cancer therapy. Multidisciplinary Teams: Patients benefit from a collaborative approach involving oncologists, immunologists, and other specialists. ...
In the face of an urgent global health threat of antimicrobial resistance (AMR), effective biomedical liquid waste management has become more crucial than ...
At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. ...
Medical History Jane is a 40-year-old, married mother of two teenage boys. She teaches at the local elementary school and has been in good health for most of her life. She has no surgical history. Her most severe ailment up to this point has been the flu at age 27. Her students are first-graders; they are often difficult to control. She also experiences the normal stresses of raising ...
Crizotinib in the first-line treatment of ALK-positive lung cancer can significantly prolong the PFS, improve the objective response rate, and improve the life quality of patients compared with chemotherapy. However, more than half of patients who have disease progression after Crizotinib treatment have intracranial progression. 2.Ceritinib ...
CASE PRESENTATION A 70-year-old female recently diagnosed with metastatic pancreatic cancer presented with acute new onset of lower back pain. The patient was taking chemotherapy, participating in a drug therapy trial, and had received radiation therapy. ...
Abstract We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. ...
The key to this patient's recovery was a blood stem cell transplant: The researchers first used chemotherapy drugs to kill the patient's own immune cells and then transplanted new cells that would not be infected by HIV. ...
"This research is very exciting because it improves the possibility of targeting very specific tumor molecules, expanding the cancers that can be treated with immunotherapy and the patient population that can benefit," said Dr. Mark Yarmarkovich, a researcher in the Maris laboratory at Philadelphia Children's Hospital and lead author of the paper. ...
Ward suggested that they test the compound’s ability to treat chemotherapy-induced peripheral neuropathy (CIPN): a burning pins-and-needles-like sensation in the extremities caused by nerve damage from chemotherapy chemicals. ...
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients. Sara Jane Ward, assistant professor of pharmacology at Temple University’s Lewis Katz School of Medicine, and Douglas Brenneman, chief ...
Basch et al. reported results from a prospective randomized study from Memorial Sloan Kettering Cancer Center evaluating the efficacy of an online symptom reporting tool [13,14]. A total of 766 patients with advanced solid tumors undergoing systemic cytotoxic chemotherapy were randomized to either an online symptom reporting platform or usual care. ...
Also at risk are those who have a compromised immune system; such as people with HIV/Aids infection, organ transplant patients or chemotherapy patients. If an adequate food source and moisture is available, mold can grow very fast. ...